BIOMAT Database Logo BIOMAT Database Logo

Downregulation of antidonor cytotoxic lymphocyte responses in recipients of donor-specific transfusions. 1990

G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Washington University School of Medicine, Department of Surgery, St. Louis, Missouri.

UI MeSH Term Description Entries
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Kinetics of antidonor mixed lymphocyte culture responses in donor specific transfusions plus azathioprine-treated patients.
February 1987, Transplantation proceedings,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions.
February 1991, Transplantation,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients.
August 1992, Transplantation,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
January 1998, Annals of transplantation,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype.
February 1990, Transplantation,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of allografted heart recipients.
December 1994, Transplantation,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Priming of cytotoxic T lymphocyte precursors by donor-specific transfusions and modulation post transplant in relation to steroid withdrawal.
December 1988, Transplantation proceedings,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.
January 1985, Transplantation,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Pretreatment with donor-specific blood transfusions in related recipients with high MLC.
March 1981, Transplantation proceedings,
G A Hadley, and N Kenyon, and C B Anderson, and T Mohanakumar
Cells of donor phenotype present in renal transplant recipients infused with donor marrow: potent regulators of antidonor immune responses of the recipient.
January 2001, Transplantation proceedings,
Copied contents to your clipboard!